Unknown

Dataset Information

0

Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation.


ABSTRACT: Immune checkpoint inhibitor therapies and allogeneic hematopoietic cell transplant (alloHCT) represent two distinct modalities that offer a chance for long-term cure in a diverse array of malignancies and have experienced many breakthroughs in recent years. Herein, we review the CD27-CD70 co-stimulatory pathway and its therapeutic potential in 1) combination with checkpoint inhibitor and other immune therapies and 2) its potential ability to serve as a novel approach in graft-versus-host disease (GVHD) prevention. We further review recent advances in the understanding of GVHD as a complex immune phenomenon between donor and host immune systems, particularly in the early stages with mixed chimerism, and potential novel therapeutic approaches to prevent the development of GVHD.

SUBMITTER: Lutfi F 

PROVIDER: S-EPMC8493876 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9728560 | biostudies-literature
| S-EPMC7973115 | biostudies-literature
| S-EPMC3128149 | biostudies-literature
| S-EPMC3750068 | biostudies-literature
| S-EPMC3696423 | biostudies-other
| S-EPMC4232384 | biostudies-literature
| S-EPMC8416782 | biostudies-literature
2020-07-10 | GSE129251 | GEO
| S-EPMC3017343 | biostudies-literature
| S-EPMC8353672 | biostudies-literature